HEADER TRANSCRIPTION 02-JUN-04 1TIL TITLE CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE BACILLUS TITLE 2 ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE ANTI-ANTI-SIGMA TITLE 3 SPOIIAA:POISED FOR PHOSPHORYLATION COMPLEX WITH ATP, CRYSTAL FORM II COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTI-SIGMA F FACTOR; COMPND 3 CHAIN: A, C, E; COMPND 4 SYNONYM: STAGE II SPORULATION PROTEIN AB; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ANTI-SIGMA F FACTOR ANTAGONIST; COMPND 10 CHAIN: B, D, F; COMPND 11 SYNONYM: STAGE II SPORULATION PROTEIN AA; COMPND 12 ENGINEERED: YES; COMPND 13 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GEOBACILLUS STEAROTHERMOPHILUS; SOURCE 3 ORGANISM_TAXID: 1422; SOURCE 4 GENE: SPOIIAB; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET21A; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: GEOBACILLUS STEAROTHERMOPHILUS; SOURCE 12 ORGANISM_TAXID: 1422; SOURCE 13 GENE: SPOIIAA; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET21A KEYWDS SPOIIAB, SPOIIA, ANTI-SIGMA, ANTI-ANTI-SIGMA, SPORULATION, SERINE KEYWDS 2 KINASEA, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR S.MASUDA,K.S.MURAKAMI,S.WANG,C.A.OLSON,J.DONIGAN,F.LEON,S.A.DARST, AUTHOR 2 E.A.CAMPBELL REVDAT 5 23-AUG-23 1TIL 1 REMARK REVDAT 4 27-OCT-21 1TIL 1 REMARK SEQADV LINK REVDAT 3 24-FEB-09 1TIL 1 VERSN REVDAT 2 20-JUL-04 1TIL 1 JRNL REVDAT 1 15-JUN-04 1TIL 0 JRNL AUTH S.MASUDA,K.S.MURAKAMI,S.WANG,C.A.OLSON,J.DONIGIAN,F.LEON, JRNL AUTH 2 S.A.DARST,E.A.CAMPBELL JRNL TITL CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE JRNL TITL 2 BACILLUS ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE JRNL TITL 3 ANTI-ANTI-SIGMA SPOIIAA. JRNL REF J.MOL.BIOL. V. 340 941 2004 JRNL REFN ISSN 0022-2836 JRNL PMID 15236958 JRNL DOI 10.1016/J.JMB.2004.05.040 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 51695 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2585 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5997 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 96 REMARK 3 SOLVENT ATOMS : 155 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1TIL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-JUN-04. REMARK 100 THE DEPOSITION ID IS D_1000022665. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-MAR-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51695 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.01000 REMARK 200 FOR THE DATA SET : 12.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.40000 REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY ID 1L0O, PDB ENTRY ID 1H4Y REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 74.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM CITRATE, 0.42 M AMMONIUM REMARK 280 SULFATE, 1.0 M LITHIUM SULFATE, PH 5.6, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 295.5K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z+1/2 REMARK 290 7555 Y,X,-Z+3/4 REMARK 290 8555 -Y,-X,-Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 128.41000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 64.20500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 192.61500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 128.41000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 192.61500 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 64.20500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSSEMBLY OF 2AB/2AA (A TETRAMER) IS REMARK 300 COMPOSED BY CHAINS A, B, C AND D. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -47.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 128.41000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 142 REMARK 465 ALA A 143 REMARK 465 LEU A 144 REMARK 465 SER A 145 REMARK 465 ASN A 146 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 LYS C 142 REMARK 465 ALA C 143 REMARK 465 LEU C 144 REMARK 465 SER C 145 REMARK 465 ASN C 146 REMARK 465 GLY D -2 REMARK 465 SER E 141 REMARK 465 LYS E 142 REMARK 465 ALA E 143 REMARK 465 LEU E 144 REMARK 465 SER E 145 REMARK 465 ASN E 146 REMARK 465 GLY F -2 REMARK 465 SER F -1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS B 0 CG ND1 CD2 CE1 NE2 REMARK 470 SER C 141 OG REMARK 470 SER D -1 OG REMARK 470 HIS D 0 CG ND1 CD2 CE1 NE2 REMARK 470 MET D 1 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 31 69.76 35.21 REMARK 500 PRO A 60 -3.71 -58.89 REMARK 500 GLU A 82 54.14 -99.00 REMARK 500 LEU A 96 -5.98 67.43 REMARK 500 LYS A 100 55.82 -141.61 REMARK 500 ASN A 127 -3.90 74.49 REMARK 500 LYS A 136 117.98 -177.24 REMARK 500 SER B 2 10.93 53.19 REMARK 500 GLN B 11 88.14 8.10 REMARK 500 ASP B 57 -167.49 -114.16 REMARK 500 ILE B 99 -74.58 -86.14 REMARK 500 VAL B 115 -75.83 -55.86 REMARK 500 ARG C 2 59.32 -154.10 REMARK 500 GLU C 71 114.54 -171.68 REMARK 500 GLU C 82 52.10 -94.09 REMARK 500 LEU C 96 -9.81 82.07 REMARK 500 LYS C 128 -59.28 -142.09 REMARK 500 VAL C 139 108.04 -53.99 REMARK 500 HIS D 0 164.41 168.12 REMARK 500 GLN D 11 79.96 24.69 REMARK 500 ASP D 12 3.58 80.48 REMARK 500 GLN D 52 32.04 -89.92 REMARK 500 ASN D 73 14.87 -68.94 REMARK 500 ALA D 104 -88.81 -54.37 REMARK 500 ARG E 2 139.60 -178.77 REMARK 500 ASN E 3 140.02 177.44 REMARK 500 ASN E 15 9.82 -62.29 REMARK 500 GLN E 29 8.02 -59.56 REMARK 500 HIS E 54 -65.79 -91.27 REMARK 500 ASN E 58 18.26 58.77 REMARK 500 GLU E 71 116.39 -173.22 REMARK 500 GLU E 82 40.42 -102.32 REMARK 500 LEU E 96 -5.37 81.32 REMARK 500 LEU E 103 49.99 -102.01 REMARK 500 GLU E 104 52.14 28.22 REMARK 500 GLU E 119 127.96 -175.99 REMARK 500 ASN E 127 -11.30 72.42 REMARK 500 LYS E 128 -71.82 -84.00 REMARK 500 MET F 1 -112.32 -96.06 REMARK 500 GLN F 11 81.53 32.07 REMARK 500 ASP F 12 -2.19 78.13 REMARK 500 ALA F 42 71.11 -106.41 REMARK 500 ASP F 57 -167.22 -119.37 REMARK 500 ASN F 73 8.11 -63.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 300 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 50 OD1 REMARK 620 2 ASN A 50 ND2 47.2 REMARK 620 3 ATP A 200 O1A 75.3 62.4 REMARK 620 4 ATP A 200 O2G 139.2 164.2 103.2 REMARK 620 5 ATP A 200 O1B 74.2 112.9 75.3 66.3 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG C 301 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN C 50 OD1 REMARK 620 2 ATP C 201 O2G 154.1 REMARK 620 3 ATP C 201 O1A 76.4 111.6 REMARK 620 4 ATP C 201 O1B 84.8 73.5 78.0 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG E 302 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN E 50 OD1 REMARK 620 2 ATP E 202 O1B 76.0 REMARK 620 3 ATP E 202 O1A 78.9 80.6 REMARK 620 4 ATP E 202 O2G 137.3 72.9 123.0 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG E 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP C 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP E 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1THN RELATED DB: PDB REMARK 900 INHIBITORY COMPLEX, CRYSTAL FORM I REMARK 900 RELATED ID: 1TH8 RELATED DB: PDB REMARK 900 INHIBITORY COMPLEX, CRYSTAL FOR II REMARK 900 RELATED ID: 1TID RELATED DB: PDB REMARK 900 POISED FOR PHOSPHORYLATION COMPLEX , CRYSTAL FORM I REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE DISCREPANCIES IN BOTH CHAINS ARE DUE TO STRAIN REMARK 999 VARIATION. DBREF 1TIL A 1 146 UNP O32727 SP2AB_BACST 1 136 DBREF 1TIL B 1 116 UNP O32726 SP2AA_BACST 1 116 DBREF 1TIL C 1 146 UNP O32727 SP2AB_BACST 1 136 DBREF 1TIL D 1 116 UNP O32726 SP2AA_BACST 1 116 DBREF 1TIL E 1 146 UNP O32727 SP2AB_BACST 1 136 DBREF 1TIL F 1 116 UNP O32726 SP2AA_BACST 1 116 SEQADV 1TIL MET A 34 UNP O32727 THR 34 SEE REMARK 999 SEQADV 1TIL HIS A 137 UNP O32727 ALA 137 SEE REMARK 999 SEQADV 1TIL ILE A 138 UNP O32727 TYR 138 SEE REMARK 999 SEQADV 1TIL VAL A 139 UNP O32727 CYS 139 SEE REMARK 999 SEQADV 1TIL LYS A 140 UNP O32727 GLU 140 SEE REMARK 999 SEQADV 1TIL SER A 141 UNP O32727 LYS 141 SEE REMARK 999 SEQADV 1TIL LYS A 142 UNP O32727 GLN 142 SEE REMARK 999 SEQADV 1TIL ALA A 143 UNP O32727 THR 143 SEE REMARK 999 SEQADV 1TIL SER A 145 UNP O32727 CYS 145 ENGINEERED MUTATION SEQADV 1TIL MET C 34 UNP O32727 THR 34 SEE REMARK 999 SEQADV 1TIL HIS C 137 UNP O32727 ALA 137 SEE REMARK 999 SEQADV 1TIL ILE C 138 UNP O32727 TYR 138 SEE REMARK 999 SEQADV 1TIL VAL C 139 UNP O32727 CYS 139 SEE REMARK 999 SEQADV 1TIL LYS C 140 UNP O32727 GLU 140 SEE REMARK 999 SEQADV 1TIL SER C 141 UNP O32727 LYS 141 SEE REMARK 999 SEQADV 1TIL LYS C 142 UNP O32727 GLN 142 SEE REMARK 999 SEQADV 1TIL ALA C 143 UNP O32727 THR 143 SEE REMARK 999 SEQADV 1TIL SER C 145 UNP O32727 CYS 145 ENGINEERED MUTATION SEQADV 1TIL MET E 34 UNP O32727 THR 34 SEE REMARK 999 SEQADV 1TIL HIS E 137 UNP O32727 ALA 137 SEE REMARK 999 SEQADV 1TIL ILE E 138 UNP O32727 TYR 138 SEE REMARK 999 SEQADV 1TIL VAL E 139 UNP O32727 CYS 139 SEE REMARK 999 SEQADV 1TIL LYS E 140 UNP O32727 GLU 140 SEE REMARK 999 SEQADV 1TIL SER E 141 UNP O32727 LYS 141 SEE REMARK 999 SEQADV 1TIL LYS E 142 UNP O32727 GLN 142 SEE REMARK 999 SEQADV 1TIL ALA E 143 UNP O32727 THR 143 SEE REMARK 999 SEQADV 1TIL SER E 145 UNP O32727 CYS 145 ENGINEERED MUTATION SEQADV 1TIL GLY B -2 UNP O32726 CLONING ARTIFACT SEQADV 1TIL SER B -1 UNP O32726 CLONING ARTIFACT SEQADV 1TIL HIS B 0 UNP O32726 CLONING ARTIFACT SEQADV 1TIL VAL B 13 UNP O32726 GLU 13 SEE REMARK 999 SEQADV 1TIL GLU B 29 UNP O32726 ASN 29 SEE REMARK 999 SEQADV 1TIL LEU B 30 UNP O32726 CYS 30 SEE REMARK 999 SEQADV 1TIL ARG B 31 UNP O32726 MET 31 SEE REMARK 999 SEQADV 1TIL GLU B 32 UNP O32726 ASN 32 SEE REMARK 999 SEQADV 1TIL GLN B 33 UNP O32726 LYS 33 SEE REMARK 999 SEQADV 1TIL VAL B 34 UNP O32726 CYS 34 SEE REMARK 999 SEQADV 1TIL THR B 35 UNP O32726 ARG 35 SEE REMARK 999 SEQADV 1TIL ASP B 36 UNP O32726 MET 36 SEE REMARK 999 SEQADV 1TIL VAL B 37 UNP O32726 CYS 37 SEE REMARK 999 SEQADV 1TIL ASN B 40 UNP O32726 LYS 40 SEE REMARK 999 SEQADV 1TIL ALA B 58 UNP O32726 SER 58 ENGINEERED MUTATION SEQADV 1TIL GLY D -2 UNP O32726 CLONING ARTIFACT SEQADV 1TIL SER D -1 UNP O32726 CLONING ARTIFACT SEQADV 1TIL HIS D 0 UNP O32726 CLONING ARTIFACT SEQADV 1TIL VAL D 13 UNP O32726 GLU 13 SEE REMARK 999 SEQADV 1TIL GLU D 29 UNP O32726 ASN 29 SEE REMARK 999 SEQADV 1TIL LEU D 30 UNP O32726 CYS 30 SEE REMARK 999 SEQADV 1TIL ARG D 31 UNP O32726 MET 31 SEE REMARK 999 SEQADV 1TIL GLU D 32 UNP O32726 ASN 32 SEE REMARK 999 SEQADV 1TIL GLN D 33 UNP O32726 LYS 33 SEE REMARK 999 SEQADV 1TIL VAL D 34 UNP O32726 CYS 34 SEE REMARK 999 SEQADV 1TIL THR D 35 UNP O32726 ARG 35 SEE REMARK 999 SEQADV 1TIL ASP D 36 UNP O32726 MET 36 SEE REMARK 999 SEQADV 1TIL VAL D 37 UNP O32726 CYS 37 SEE REMARK 999 SEQADV 1TIL ASN D 40 UNP O32726 LYS 40 SEE REMARK 999 SEQADV 1TIL ALA D 58 UNP O32726 SER 58 ENGINEERED MUTATION SEQADV 1TIL GLY F -2 UNP O32726 CLONING ARTIFACT SEQADV 1TIL SER F -1 UNP O32726 CLONING ARTIFACT SEQADV 1TIL HIS F 0 UNP O32726 CLONING ARTIFACT SEQADV 1TIL VAL F 13 UNP O32726 GLU 13 SEE REMARK 999 SEQADV 1TIL GLU F 29 UNP O32726 ASN 29 SEE REMARK 999 SEQADV 1TIL LEU F 30 UNP O32726 CYS 30 SEE REMARK 999 SEQADV 1TIL ARG F 31 UNP O32726 MET 31 SEE REMARK 999 SEQADV 1TIL GLU F 32 UNP O32726 ASN 32 SEE REMARK 999 SEQADV 1TIL GLN F 33 UNP O32726 LYS 33 SEE REMARK 999 SEQADV 1TIL VAL F 34 UNP O32726 CYS 34 SEE REMARK 999 SEQADV 1TIL THR F 35 UNP O32726 ARG 35 SEE REMARK 999 SEQADV 1TIL ASP F 36 UNP O32726 MET 36 SEE REMARK 999 SEQADV 1TIL VAL F 37 UNP O32726 CYS 37 SEE REMARK 999 SEQADV 1TIL ASN F 40 UNP O32726 LYS 40 SEE REMARK 999 SEQADV 1TIL ALA F 58 UNP O32726 SER 58 ENGINEERED MUTATION SEQRES 1 A 146 MET ARG ASN GLU MET HIS LEU GLN PHE SER ALA ARG SER SEQRES 2 A 146 GLU ASN GLU SER PHE ALA ARG VAL THR VAL ALA ALA PHE SEQRES 3 A 146 VAL ALA GLN LEU ASP PRO THR MET ASP GLU LEU THR GLU SEQRES 4 A 146 ILE LYS THR VAL VAL SER GLU ALA VAL THR ASN ALA ILE SEQRES 5 A 146 ILE HIS GLY TYR ASN ASN ASP PRO ASN GLY ILE VAL SER SEQRES 6 A 146 ILE SER VAL ILE ILE GLU ASP GLY VAL VAL HIS LEU THR SEQRES 7 A 146 VAL ARG ASP GLU GLY VAL GLY ILE PRO ASP ILE GLU GLU SEQRES 8 A 146 ALA ARG GLN PRO LEU PHE THR THR LYS PRO GLU LEU GLU SEQRES 9 A 146 ARG SER GLY MET GLY PHE THR ILE MET GLU ASN PHE MET SEQRES 10 A 146 ASP GLU VAL ILE VAL GLU SER GLU VAL ASN LYS GLY THR SEQRES 11 A 146 THR VAL TYR LEU LYS LYS HIS ILE VAL LYS SER LYS ALA SEQRES 12 A 146 LEU SER ASN SEQRES 1 B 119 GLY SER HIS MET SER LEU ALA ILE ASP LEU GLU VAL LYS SEQRES 2 B 119 GLN ASP VAL LEU ILE VAL ARG LEU SER GLY GLU LEU ASP SEQRES 3 B 119 HIS HIS THR ALA GLU GLU LEU ARG GLU GLN VAL THR ASP SEQRES 4 B 119 VAL LEU GLU ASN ARG ALA ILE ARG HIS ILE VAL LEU ASN SEQRES 5 B 119 LEU GLY GLN LEU THR PHE MET ASP ALA SER GLY LEU GLY SEQRES 6 B 119 VAL ILE LEU GLY ARG TYR LYS GLN ILE LYS ASN VAL GLY SEQRES 7 B 119 GLY GLN MET VAL VAL CYS ALA VAL SER PRO ALA VAL LYS SEQRES 8 B 119 ARG LEU PHE ASP MET SER GLY LEU PHE LYS ILE ILE ARG SEQRES 9 B 119 VAL GLU ALA ASP GLU GLN PHE ALA LEU GLN ALA LEU GLY SEQRES 10 B 119 VAL ALA SEQRES 1 C 146 MET ARG ASN GLU MET HIS LEU GLN PHE SER ALA ARG SER SEQRES 2 C 146 GLU ASN GLU SER PHE ALA ARG VAL THR VAL ALA ALA PHE SEQRES 3 C 146 VAL ALA GLN LEU ASP PRO THR MET ASP GLU LEU THR GLU SEQRES 4 C 146 ILE LYS THR VAL VAL SER GLU ALA VAL THR ASN ALA ILE SEQRES 5 C 146 ILE HIS GLY TYR ASN ASN ASP PRO ASN GLY ILE VAL SER SEQRES 6 C 146 ILE SER VAL ILE ILE GLU ASP GLY VAL VAL HIS LEU THR SEQRES 7 C 146 VAL ARG ASP GLU GLY VAL GLY ILE PRO ASP ILE GLU GLU SEQRES 8 C 146 ALA ARG GLN PRO LEU PHE THR THR LYS PRO GLU LEU GLU SEQRES 9 C 146 ARG SER GLY MET GLY PHE THR ILE MET GLU ASN PHE MET SEQRES 10 C 146 ASP GLU VAL ILE VAL GLU SER GLU VAL ASN LYS GLY THR SEQRES 11 C 146 THR VAL TYR LEU LYS LYS HIS ILE VAL LYS SER LYS ALA SEQRES 12 C 146 LEU SER ASN SEQRES 1 D 119 GLY SER HIS MET SER LEU ALA ILE ASP LEU GLU VAL LYS SEQRES 2 D 119 GLN ASP VAL LEU ILE VAL ARG LEU SER GLY GLU LEU ASP SEQRES 3 D 119 HIS HIS THR ALA GLU GLU LEU ARG GLU GLN VAL THR ASP SEQRES 4 D 119 VAL LEU GLU ASN ARG ALA ILE ARG HIS ILE VAL LEU ASN SEQRES 5 D 119 LEU GLY GLN LEU THR PHE MET ASP ALA SER GLY LEU GLY SEQRES 6 D 119 VAL ILE LEU GLY ARG TYR LYS GLN ILE LYS ASN VAL GLY SEQRES 7 D 119 GLY GLN MET VAL VAL CYS ALA VAL SER PRO ALA VAL LYS SEQRES 8 D 119 ARG LEU PHE ASP MET SER GLY LEU PHE LYS ILE ILE ARG SEQRES 9 D 119 VAL GLU ALA ASP GLU GLN PHE ALA LEU GLN ALA LEU GLY SEQRES 10 D 119 VAL ALA SEQRES 1 E 146 MET ARG ASN GLU MET HIS LEU GLN PHE SER ALA ARG SER SEQRES 2 E 146 GLU ASN GLU SER PHE ALA ARG VAL THR VAL ALA ALA PHE SEQRES 3 E 146 VAL ALA GLN LEU ASP PRO THR MET ASP GLU LEU THR GLU SEQRES 4 E 146 ILE LYS THR VAL VAL SER GLU ALA VAL THR ASN ALA ILE SEQRES 5 E 146 ILE HIS GLY TYR ASN ASN ASP PRO ASN GLY ILE VAL SER SEQRES 6 E 146 ILE SER VAL ILE ILE GLU ASP GLY VAL VAL HIS LEU THR SEQRES 7 E 146 VAL ARG ASP GLU GLY VAL GLY ILE PRO ASP ILE GLU GLU SEQRES 8 E 146 ALA ARG GLN PRO LEU PHE THR THR LYS PRO GLU LEU GLU SEQRES 9 E 146 ARG SER GLY MET GLY PHE THR ILE MET GLU ASN PHE MET SEQRES 10 E 146 ASP GLU VAL ILE VAL GLU SER GLU VAL ASN LYS GLY THR SEQRES 11 E 146 THR VAL TYR LEU LYS LYS HIS ILE VAL LYS SER LYS ALA SEQRES 12 E 146 LEU SER ASN SEQRES 1 F 119 GLY SER HIS MET SER LEU ALA ILE ASP LEU GLU VAL LYS SEQRES 2 F 119 GLN ASP VAL LEU ILE VAL ARG LEU SER GLY GLU LEU ASP SEQRES 3 F 119 HIS HIS THR ALA GLU GLU LEU ARG GLU GLN VAL THR ASP SEQRES 4 F 119 VAL LEU GLU ASN ARG ALA ILE ARG HIS ILE VAL LEU ASN SEQRES 5 F 119 LEU GLY GLN LEU THR PHE MET ASP ALA SER GLY LEU GLY SEQRES 6 F 119 VAL ILE LEU GLY ARG TYR LYS GLN ILE LYS ASN VAL GLY SEQRES 7 F 119 GLY GLN MET VAL VAL CYS ALA VAL SER PRO ALA VAL LYS SEQRES 8 F 119 ARG LEU PHE ASP MET SER GLY LEU PHE LYS ILE ILE ARG SEQRES 9 F 119 VAL GLU ALA ASP GLU GLN PHE ALA LEU GLN ALA LEU GLY SEQRES 10 F 119 VAL ALA HET MG A 300 1 HET ATP A 200 31 HET MG C 301 1 HET ATP C 201 31 HET MG E 302 1 HET ATP E 202 31 HETNAM MG MAGNESIUM ION HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE FORMUL 7 MG 3(MG 2+) FORMUL 8 ATP 3(C10 H16 N5 O13 P3) FORMUL 13 HOH *155(H2 O) HELIX 1 1 SER A 13 GLN A 29 1 17 HELIX 2 2 THR A 33 HIS A 54 1 22 HELIX 3 3 ASP A 88 ARG A 93 1 6 HELIX 4 4 LYS A 100 GLU A 104 5 5 HELIX 5 5 MET A 108 MET A 117 1 10 HELIX 6 6 ASP B 23 ARG B 41 1 19 HELIX 7 7 ASP B 57 ASN B 73 1 17 HELIX 8 8 SER B 84 GLY B 95 1 12 HELIX 9 9 ASP B 105 GLY B 114 1 10 HELIX 10 10 SER C 13 ALA C 28 1 16 HELIX 11 11 GLN C 29 ASP C 31 5 3 HELIX 12 12 THR C 33 HIS C 54 1 22 HELIX 13 13 ASP C 88 ARG C 93 1 6 HELIX 14 14 LYS C 100 GLU C 104 5 5 HELIX 15 15 MET C 108 MET C 117 1 10 HELIX 16 16 ASP D 23 ARG D 41 1 19 HELIX 17 17 ASP D 57 ASN D 73 1 17 HELIX 18 18 SER D 84 ASP D 92 1 9 HELIX 19 19 MET D 93 ILE D 100 5 8 HELIX 20 20 ASP D 105 GLY D 114 1 10 HELIX 21 21 GLU E 14 GLN E 29 1 16 HELIX 22 22 THR E 33 HIS E 54 1 22 HELIX 23 23 ASP E 88 ARG E 93 1 6 HELIX 24 24 LYS E 100 GLU E 104 5 5 HELIX 25 25 MET E 108 MET E 117 1 10 HELIX 26 26 ASP F 23 ARG F 41 1 19 HELIX 27 27 ASP F 57 ASN F 73 1 17 HELIX 28 28 SER F 84 ASP F 92 1 9 HELIX 29 29 MET F 93 ILE F 100 5 8 HELIX 30 30 ASP F 105 LEU F 113 1 9 SHEET 1 A10 GLU A 119 GLU A 125 0 SHEET 2 A10 GLY A 129 HIS A 137 -1 O TYR A 133 N ILE A 121 SHEET 3 A10 VAL A 74 ASP A 81 -1 N LEU A 77 O LEU A 134 SHEET 4 A10 ILE A 63 GLU A 71 -1 N SER A 65 O ARG A 80 SHEET 5 A10 ARG A 2 SER A 10 -1 N LEU A 7 O ILE A 66 SHEET 6 A10 GLU C 4 SER C 10 -1 O GLN C 8 N HIS A 6 SHEET 7 A10 ILE C 63 GLU C 71 -1 O ILE C 66 N LEU C 7 SHEET 8 A10 VAL C 74 ASP C 81 -1 O ARG C 80 N SER C 65 SHEET 9 A10 GLY C 129 HIS C 137 -1 O VAL C 132 N VAL C 79 SHEET 10 A10 GLU C 119 GLU C 125 -1 N GLU C 123 O THR C 131 SHEET 1 B 5 LEU B 3 LYS B 10 0 SHEET 2 B 5 VAL B 13 LEU B 22 -1 O VAL B 13 N LYS B 10 SHEET 3 B 5 HIS B 45 MET B 56 1 O ASN B 49 N VAL B 16 SHEET 4 B 5 MET B 78 CYS B 81 1 O VAL B 79 N LEU B 48 SHEET 5 B 5 ARG B 101 GLU B 103 1 O GLU B 103 N VAL B 80 SHEET 1 C 5 LEU D 3 LYS D 10 0 SHEET 2 C 5 VAL D 13 LEU D 22 -1 O ILE D 15 N GLU D 8 SHEET 3 C 5 HIS D 45 MET D 56 1 O ASN D 49 N VAL D 16 SHEET 4 C 5 GLN D 77 CYS D 81 1 O CYS D 81 N LEU D 48 SHEET 5 C 5 ARG D 101 GLU D 103 1 O ARG D 101 N VAL D 80 SHEET 1 D 5 ASN E 3 SER E 10 0 SHEET 2 D 5 ILE E 63 GLU E 71 -1 O ILE E 66 N LEU E 7 SHEET 3 D 5 VAL E 74 ASP E 81 -1 O ARG E 80 N SER E 65 SHEET 4 D 5 GLY E 129 HIS E 137 -1 O LEU E 134 N LEU E 77 SHEET 5 D 5 GLU E 119 GLU E 125 -1 N GLU E 123 O THR E 131 SHEET 1 E 5 LEU F 3 LYS F 10 0 SHEET 2 E 5 VAL F 13 LEU F 22 -1 O SER F 19 N ALA F 4 SHEET 3 E 5 HIS F 45 MET F 56 1 O THR F 54 N GLY F 20 SHEET 4 E 5 MET F 78 CYS F 81 1 O CYS F 81 N LEU F 48 SHEET 5 E 5 ARG F 101 GLU F 103 1 O ARG F 101 N VAL F 80 LINK OD1 ASN A 50 MG MG A 300 1555 1555 2.06 LINK ND2 ASN A 50 MG MG A 300 1555 1555 3.06 LINK O1A ATP A 200 MG MG A 300 1555 1555 2.93 LINK O2G ATP A 200 MG MG A 300 1555 1555 2.27 LINK O1B ATP A 200 MG MG A 300 1555 1555 2.97 LINK OD1 ASN C 50 MG MG C 301 1555 1555 2.19 LINK O2G ATP C 201 MG MG C 301 1555 1555 1.98 LINK O1A ATP C 201 MG MG C 301 1555 1555 2.66 LINK O1B ATP C 201 MG MG C 301 1555 1555 2.88 LINK OD1 ASN E 50 MG MG E 302 1555 1555 2.05 LINK O1B ATP E 202 MG MG E 302 1555 1555 2.88 LINK O1A ATP E 202 MG MG E 302 1555 1555 2.80 LINK O2G ATP E 202 MG MG E 302 1555 1555 2.44 SITE 1 AC1 3 GLU A 46 ASN A 50 ATP A 200 SITE 1 AC2 3 GLU C 46 ASN C 50 ATP C 201 SITE 1 AC3 4 GLU E 46 ASN E 50 GLY E 109 ATP E 202 SITE 1 AC4 24 GLU A 46 ASN A 50 ALA A 51 HIS A 54 SITE 2 AC4 24 GLY A 55 ASP A 81 GLY A 85 ILE A 86 SITE 3 AC4 24 ALA A 92 THR A 98 THR A 99 ARG A 105 SITE 4 AC4 24 SER A 106 GLY A 107 MET A 108 GLY A 109 SITE 5 AC4 24 PHE A 110 THR A 130 MG A 300 HOH A 301 SITE 6 AC4 24 HOH A 305 HOH A 316 HOH A 320 ALA B 58 SITE 1 AC5 22 GLU C 46 ASN C 50 HIS C 54 GLY C 55 SITE 2 AC5 22 ASP C 81 GLY C 85 ILE C 86 ALA C 92 SITE 3 AC5 22 THR C 98 THR C 99 ARG C 105 SER C 106 SITE 4 AC5 22 GLY C 107 MET C 108 GLY C 109 PHE C 110 SITE 5 AC5 22 THR C 130 MG C 301 HOH C 308 HOH C 315 SITE 6 AC5 22 HOH C 329 ALA D 58 SITE 1 AC6 20 GLU E 46 ASN E 50 ALA E 51 HIS E 54 SITE 2 AC6 20 GLY E 55 ASP E 81 ILE E 86 ALA E 92 SITE 3 AC6 20 THR E 98 THR E 99 ARG E 105 SER E 106 SITE 4 AC6 20 GLY E 107 MET E 108 GLY E 109 PHE E 110 SITE 5 AC6 20 THR E 130 MG E 302 HOH E 318 ALA F 58 CRYST1 115.133 115.133 256.820 90.00 90.00 90.00 P 41 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008686 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008686 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003894 0.00000